What Nurses Need to Know About the Endocannabinoid System and Cannabis



Marijuana might not be medicine to the D.E.A., but California nurses can get continuing education credits for studying safe and effective use of "Mary's stuff" in Berkeley this fall.

Medical cannabis consultant and addictions nurse consultant Mary Lynn Mathre — RN, MSN, CARN, a co-founder of Patients Out of Time and the President of the American Cannabis Nurses Association — in conjunction with Christine Wagner, licensed California attorney practicing in the area of cannabis law, will be leading a seminar titled "The Endocannabinoid System and Cannabis: What Nurses Need to Know" Tuesday Oct. 23 at 8:30 a.m. at the David Brower Center, in Berkeley.

External glands called trichomes manufacture the active ingrediants in cannabis: cannabinoids
  • David Downs
  • External glands called trichomes manufacture the active ingredients in cannabis: cannabinoids

The California Board of Registered Nursing has approved Continuing Education Credits for nurses attending the $140, six-hour seminar, which "will include an overview of cannabis, the various cannabinoids (endogenous, phyto-cannabinoids and pharmaceutical cannabinoid products) and the newly discovered endogenous cannabinoid system (ECS) that is present in all humans. By understanding the ECS, it becomes more clear as to how and why cannabis is a safe and effective medication for a wide array of illnesses and conditions. The nurse’s role in patient care and education regarding the safe use of cannabis, including ingestion methodologies and interactions with prescription opiates, will be discussed. State and federal laws regarding cannabis as medicine will also be presented."

The seminar is sponsored by Patients Out of Time, a 501(c)(3) non-profit organization "whose mission is to educate all disciplines of health care professionals, their specialty and professional organizations, and the public at large about medical cannabis."